Q32 Bio Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $4.00K.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $997.00K.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $380.00K, a 2433.33% increase year-over-year.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $15.00K.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.69M, a 1498.11% increase from fiscal 2023.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $106.00K, a 10500.00% increase from fiscal 2022.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.00K, a 99.31% decline from fiscal 2021.
- Q32 Bio Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $145.00K, a 17.61% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $4.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $1.69M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $997.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $380.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $106.00K 10-K · filed 2025-03-11 | |
| 2023-06-30 | $15.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $15.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $1.00K 10-K · filed 2024-03-13 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $145.00K 10-K · filed 2023-03-09 | |
| 2021-06-30 | $2.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $143.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $176.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $9.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $16.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $135.00K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $351.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $209.00K 10-Q · filed 2020-11-09 | $326.79K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $55.00K 10-Q · filed 2020-11-09 | $77.79K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-03-31 | $21.00K 10-Q · filed 2020-11-09 | $38.79K derived: sum of 4 quarters · filed 2020-11-09 |
| 2018-12-31 | $41.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $87.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$40.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $16.00K 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $69.00K 10-Q · filed 2019-11-12 |